Advisory Board

Boadie W. Dunlop, MD, is an Assistant Professor and Director of the Mood and Anxiety Disorders Program in the Department of Psychiatry and Behavioral Sciences at Emory University in Atlanta, Georgia. The primary focus of his work is on the pathophysiology and treatment of major depressive disorder and anxiety disorders. He has a particular interest in the role of dopamine dysfunction and associated deficits in motivation, reward, and decision-making in psychiatric illnesses. Dr. Dunlop currently serves as a principal investigator for several industry-sponsored trials of emerging treatment approaches to the treatment of major depression and generalized anxiety disorder. He also serves as a co-investigator for federally sponsored projects exploring biological predictors of response to antidepressant treatments. Additionally, Dr. Dunlop has served as an investigator on projects exploring the efficacy of transcranial magnetic stimulation (TMS) in treatment-resistant depression and the role of dopamine-related genes in cognitive processing tasks.

Dr. Dunlop has co-authored a book, Contemporary Diagnosis and Management of Anxiety Disorders, and three book chapters on the neurobiologic aspects of major depression and antidepressant medications. Among his peer-reviewed publications are studies of the metabolic side effects of antipsychotics, adjunctive treatments for major depression and social phobia, and the role of dopamine in the pathophysiology of major depression. Dr. Dunlop also serves as a psychotherapy supervisor and coordinator for education on anxiety disorders for Emory psychiatry residents and medical students.

Susan G. Kornstein, MD, is Professor of Psychiatry and Obstetrics and Gynecology and Chair of the Division of Ambulatory Care Psychiatry at the Medical College of Virginia (MCV), Virginia Commonwealth University (VCU), in Richmond. In addition, she is Director of the VCU Mood Disorders Institute, Director of the VCU Institute for Women’s Health, and Director of Psychiatric Services for MCV Women’s Healthcare in Richmond.

After earning her undergraduate and medical degrees at Brown University in Providence, Rhode Island, she completed her residency in psychiatry and a fellowship in consultation-liaison psychiatry at the Medical College of Virginia.

Dr. Kornstein is a nationally recognized leader in mental health issues for women. She has authored or co-authored more than 100 articles, chapters, and abstracts, and has given many national and international presentations concerning topics related to depression and women’s health. She is co-editor of Women’s Mental Health: A Comprehensive Textbook. She has been principal investigator for more than 30 research studies concerning depression, anxiety disorders, and premenstrual syndrome. Dr. Kornstein serves as a reviewer for 15 journals and is on the editorial board of two journals. She is a fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. Dr. Kornstein is the recipient of the Distinguished Service Award presented by the Psychiatric Society of Virginia, the Research Scientist Award from the MCV Foundation, and the Richmond YWCA Outstanding Woman of the Year Award for Health and Science.

George I. Papakostas is an Assistant Professor of Psychiatry at Harvard Medical School and Clinical Assistant in Psychiatry in the Department of Psychiatry at Massachusetts General Hospital, Boston, Massachusetts. He is also a Staff Physician and Psychiatric Consultant for the Neuroendocrine Unit in the Department of Medicine, and a member of the Scientific Advisory Board of the Mallinckrodt General Clinical Research Center at Massachusetts General Hospital. The focus of Dr. Papakostas’ research includes the pharmacotherapy of major depressive disorder, including treatment-resistant depression, with an emphasis on the use of adjunctive treatment strategies (augmentation); the placebo effect and its relevance to clinical-trial design in depression; and neuroendocrine and metabolic issues in depression, with a particular emphasis on their relevance to clinical improvement during pharmacotherapy. Dr. Papakostas has received numerous national and international research awards from sources including the American College of Neuropsychopharmacology, the Collegium Internationale Neuropsychopharmacologium, the New Clinical Drug Evaluation Unit of the National Institute of Mental Health, the World Federation of Societies of Biological Psychiatry, the International College of Psychosomatic Medicine, and the American Foundation for Suicide Prevention. He is an author or co-author of more than 90 clinical and scientific publications and book chapters. His publications have appeared in Biological Psychiatry, The Journal of Clinical Psychiatry, and the Journal of Clinical Psychopharmacology, among other journals. He is also on the editorial board of Psychiatry Research and Directions in Psychiatry, and has served as a reviewer for more than 30 journals, including the Archives of General Psychiatry, Biological Psychiatry, and The Journal of Clinical Psychiatry. Dr. Papakostas is often invited to lecture on a wide range of topics pertaining to the treatment of depression throughout the United States and abroad.

Dr. Papakostas attended medical school at the New York University School of Medicine. He completed his residency in Adult Psychiatry at Massachusetts General Hospital and McLean Hospital and a fellowship in clinical neuropsychopharmacology at Massachusetts General Hospital that was funded by the American College of Neuropsychopharmacology.

A member of the faculty of the University of Pittsburgh Medical Center and the Western Psychiatric Institute and Clinic for more than 23 years, Michael E. Thase, MD, has recently joined the faculty of the University of Pennsylvania School of Medicine, where he is Professor of Psychiatry. An active clinical investigator, Dr. Thase’s research focuses on the assessment and treatment of mood disorders, including the correlates of differential response to various treatments for depression and bipolar affective disorder. A 1979 graduate of the Ohio State University College of Medicine, Dr. Thase is a Distinguished Fellow of the American Psychiatric Association and a Founding Fellow of the Academy of Cognitive Therapy, and he has been elected to membership in the American College of Psychiatrists and the American College of Neuropsychopharmacology. Dr. Thase has authored or co-authored nearly 500 scientific articles and book chapters, as well as 15 books.